Ronald Hans Wilmar Lorijn

Amsterdam Molecular Therapeutics (AMT) Holding NV engages in the development of human gene based therapies. The company has a product pipeline of several gene therapy products in development for hemophilia B, acute intermittent porphyria, Parkinson's disease and SanfilippoB. It is expected to be finally dissolved in September 2012. Amsterdam Molecular Therapeutics (AMT) Holding was founded by Sander J. H. van Deventer and John J. P. Kastelein on March 20, 1998 and is headquartered in Amsterdam, Netherlands.

Esperite NV was a diversified biotech global group. The firm specialized in Immunotherapy, Regenerative Medicine, and Precision Medicine. The company was founded by Johan Paul Georges Goossens and Marc Jan Waeterschoot on March 8, 2000 and was headquartered in Zutphen, the Netherlands.

Pepscan Therapeutics BV develops immunotherapeutic products in oncology. The company was founded in 2000 and is headquartered in Lelystad, the Netherlands.

nLife Therapeutics SL develops and manufactures pharmaceutical preparations. It specializes in oligonucleotides as therapeutic agents for central nervous system and neuromuscular disorders. The company was founded by Andres Pablo Montefeltro on September 24, 2009 and is headquartered in Armilla, Spain.

Janssen Biologics BV manufactures, acquires and markets biopharmaceutical therapies. The firms products focus on cardiovascular and immunological disorders, and cancer. The company was founded in 1984 and is headquartered in Leiden, the Netherlands.

Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA.

NeuExCell Therapeutics, Inc. operates as a biotechnology company. The company is headquartered in State College, PA.